Regeneron Pharmaceuticals Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $8.76B | $1.47B |
| FY2019 | $0 | $11.09B | $1.62B |
| FY2020 | $1.98B | $11.03B | $2.19B |
| FY2021 | $1.98B | $18.77B | $2.89B |
| FY2022 | $1.98B | $22.66B | $3.11B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $8.76B | $1.47B |
| FY2019 | $0 | $11.09B | $1.62B |
| FY2020 | $1.98B | $11.03B | $2.19B |
| FY2021 | $1.98B | $18.77B | $2.89B |
| FY2022 | $1.98B | $22.66B | $3.11B |